STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Clinical trials for STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare, aggressive thyroid cancer: drug combo shows promise
Disease control OngoingThis phase 2 trial tests whether combining lenvatinib (a targeted drug that blocks cancer growth) with pembrolizumab (an immunotherapy that helps the immune system attack cancer) can improve outcomes for people with advanced anaplastic thyroid cancer that cannot be surgically rem…
Matched conditions: STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Immunotherapy cocktail takes on deadly thyroid cancer
Disease control OngoingThis phase 2 trial tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy can help people with anaplastic or poorly differentiated thyroid cancer live longer. About 50 patients with advanced or inoperable cancer are receiving different drug combinations…
Matched conditions: STAGE IVC THYROID GLAND ANAPLASTIC CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC